| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/18/2013 | US8466143 Azepine derivatives as pharmaceutical agents |
| 06/18/2013 | US8466142 Cephalotaxus esters, methods of synthesis, and uses thereof |
| 06/18/2013 | US8466141 Pharmaceutical composition for the treatment or prevention of diseases involving obesity, diabetes, metabolic syndrome, neuro-degenerative diseases and mitochondria dysfunction diseases |
| 06/18/2013 | US8466139 Formulation |
| 06/18/2013 | US8466138 Testosterone gel and method of use |
| 06/18/2013 | US8466137 Testosterone gel and method of use |
| 06/18/2013 | US8466136 Testosterone gel and method of use |
| 06/18/2013 | US8466135 Hair treatment compositions |
| 06/18/2013 | US8466134 Aqueous compositions containing corticosteroids for nasal and pulmonary delivery |
| 06/18/2013 | US8466133 Polylactides compositions and uses thereof |
| 06/18/2013 | US8466132 Substituted tetracycline compounds |
| 06/18/2013 | US8466131 Ligands specific for cannabinoid receptor subtype 2 |
| 06/18/2013 | US8466130 Mitochondria targeted cationic anti-oxidant compounds for prevention, therapy or treatment of hyper-proliferative disease, neoplasias and cancers |
| 06/18/2013 | US8466129 Method of preventing and treating airway remodeling and pulmonary inflammation using A2B adenosine receptor antagonists |
| 06/18/2013 | US8466128 sodium hyaluronate mixture for topical administration to a mammalian for treating skin disorders; fungicides, corticosteroids, preservatives, antiacne agents, antibiotics |
| 06/18/2013 | US8466127 Pegylated and fatty acid grafted chitosan oligosaccharide, synthesis method and application for drug delivery system |
| 06/18/2013 | US8466126 Composition and methods for promoting lush hair growth |
| 06/18/2013 | US8466125 Pharmaceutical compositions comprising modified fucans and methods relating thereto |
| 06/18/2013 | US8466120 Oligomeric compounds and compositions for use in modulation of pri-miRNAs |
| 06/18/2013 | US8466115 Spirocyclic isoxazoline derivatives as antiparasitic agents |
| 06/18/2013 | US8466114 Glycoside derivatives and uses thereof |
| 06/18/2013 | US8466113 4-isopropylphenyl glucitol compounds as SGLT1 inhibitors |
| 06/18/2013 | US8466102 Antimicrobial cationic peptides and formulations thereof |
| 06/18/2013 | US8465778 Method of making tyrosine kinase microspheres |
| 06/18/2013 | US8465777 Diffusion-controlled dosage form and method of fabrication including three dimensional printing |
| 06/18/2013 | US8465774 Sequestered antagonist formulations |
| 06/18/2013 | US8465767 Mixture with tablet distegrant; sustained release; embedding water soluble particle in plastic membrane coating ; stomach disorders |
| 06/18/2013 | US8465762 Dermal application system for aminolevulinic acid-derivatives |
| 06/18/2013 | US8465758 Drug delivery from stents |
| 06/18/2013 | US8465737 Three-dimensional structure of complement receptor type 2 and uses thereof |
| 06/18/2013 | US8465731 Probiotic color cosmetic compositions and methods |
| 06/18/2013 | US8464706 Drug delivery apparatus |
| 06/18/2013 | CA2812178A1 Methods for the synthesis of plasmalogens and plasmalogen derivatives, and therapeutic uses thereof |
| 06/18/2013 | CA2725698C Tetomilast polymorphs |
| 06/18/2013 | CA2718007C The use of medium chain dicarboxylic acids and derivates thereof in the treatment of metabolic disorders |
| 06/18/2013 | CA2705681C Corticosteroid compositions |
| 06/18/2013 | CA2685723C Morphinan compounds |
| 06/18/2013 | CA2683695C 3-amido-pyrrolo[3,4-c]pyrazole-5(1h,4h,6h) carbaldehyde derivatives |
| 06/18/2013 | CA2615700C 1,4-dihydropyridine-fused heterocycles, process for preparing the same, use and compositions containing them |
| 06/18/2013 | CA2608496C Imidazoquinolines as lipid kinase inhibitors |
| 06/18/2013 | CA2595218C Indole derivatives having inhibitory activity against sodium-dependent glucose transporter |
| 06/18/2013 | CA2571405C Composition and method for treating hemorrhoids and/or anorectal disorders |
| 06/18/2013 | CA2567506C Cyclic amide derivatives, and their production and use as antithrombotic agents |
| 06/18/2013 | CA2566898C Tri- and bi-cyclic heteroaryl histamine-3 receptor ligands |
| 06/18/2013 | CA2566212C Heteroaryl-substituted cyclohexyl-1,4-diamine derivatives |
| 06/18/2013 | CA2563489C Topical methadone compositions and methods for using the same |
| 06/18/2013 | CA2561558C Quinolinone-carboxamide compounds as 5-ht4 receptor agonists |
| 06/18/2013 | CA2560896C Imidazole compounds |
| 06/18/2013 | CA2554635C Compounds, compositions containing such compounds and methods of treatment of autoimmune diseases using such compounds |
| 06/18/2013 | CA2546637C Colonic purgative composition with soluble binding agent |
| 06/18/2013 | CA2532800C Anaplastic lymphoma kinase modulators and methods of use |
| 06/18/2013 | CA2531140C 2-imino-4-(thio) oxo-5-polycyclovinylazolines for use as pi3 kinase inhibitors |
| 06/18/2013 | CA2524047C Immunosuppressant compounds and compositions |
| 06/18/2013 | CA2483656C Reduced formate poly(alkylene oxide) for a controlled release dosage form of reboxetine |
| 06/18/2013 | CA2475923C Oral dosage form containing a pde 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient |
| 06/18/2013 | CA2468463C Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers |
| 06/18/2013 | CA2463459C Novel use of pulmonary surfactant |
| 06/18/2013 | CA2429097C Composition of solutions for organ protection |
| 06/18/2013 | CA2267077C Methods for treating skin pigmentation |
| 06/17/2013 | CA2841173A1 Uses of labeled hsp90 inhibitors |
| 06/16/2013 | CA2762355A1 Methods and compositions for treatments for administration to the penis |
| 06/15/2013 | CA2771798A1 Ibudilast for relieving negative effects of medication overuse headache |
| 06/13/2013 | WO2013086526A1 Liposomal drug encapsulation |
| 06/13/2013 | WO2013086515A1 Compositions and methods for the prevention or treatment of diabetic complications |
| 06/13/2013 | WO2013086496A2 1-substituted 4-arylpiperazine as kappa opioid receptor antagonists |
| 06/13/2013 | WO2013086467A1 Benzotriazine oxides as drugs targeting mycobacterium tuberculosis |
| 06/13/2013 | WO2013086451A2 Pak inhibitors for the treatment of cancer |
| 06/13/2013 | WO2013086433A1 Sirna compositions and methods for inhibiting gene expression in tumor initiating cells of breast cancer |
| 06/13/2013 | WO2013086425A1 The hydrobromide salt of pridopidine |
| 06/13/2013 | WO2013086379A2 Methods and compositions for treating antiprogestin-resistant cancers |
| 06/13/2013 | WO2013086354A1 Biodegradable lipids for the delivery of active agents |
| 06/13/2013 | WO2013086344A1 Combination compositions and methods of treatment |
| 06/13/2013 | WO2013086330A1 Nutritional compositions comprising curcumin and docosahexaenoic acid for improving cognition |
| 06/13/2013 | WO2013086327A1 Nutritional compositions comprising curcumin and phosphatidylserine-docosahexaenoic acid for improving cognition |
| 06/13/2013 | WO2013086323A2 Supplemented oil compositions and methods for improved health |
| 06/13/2013 | WO2013086312A1 Oral formulations for treating metal overload |
| 06/13/2013 | WO2013086308A1 Compositions and methods for treating brain cancer |
| 06/13/2013 | WO2013086266A2 Allosteric modulators of 5-hydroxytryptamine 2c receptor (5-ht2cr) |
| 06/13/2013 | WO2013086229A1 Bicyclic aryl and heteroaryl sodium channel inhibitors |
| 06/13/2013 | WO2013086208A1 Substituted pyrimidinone-phenyl-pyrimidinyl compounds |
| 06/13/2013 | WO2013086200A1 Composition and method for neuropeptide s receptor (npsr) antagonists |
| 06/13/2013 | WO2013086196A1 Topical formulation for administering a compound |
| 06/13/2013 | WO2013086181A1 Biocidal compositions and methods of using the same |
| 06/13/2013 | WO2013086133A1 Methods and compositions for treating viral diseases |
| 06/13/2013 | WO2013086015A1 Medical organogel processes and compositions |
| 06/13/2013 | WO2013086002A1 Compositions, process of preparation of said compositions and method of treating cancer |
| 06/13/2013 | WO2013085998A1 Therapeutic compositions and related methods of use |
| 06/13/2013 | WO2013085957A1 Substituted piperidinyl-pyridazinyl derivatives useful as scd 1 inhibitors |
| 06/13/2013 | WO2013085954A1 Substituted piperidinyl-carboxamide derivatives useful as scd 1 inhibitors |
| 06/13/2013 | WO2013085922A1 Phosphate esters of noribogaine |
| 06/13/2013 | WO2013085904A1 Oral spray formulations and methods for administration of sildenafil |
| 06/13/2013 | WO2013085902A1 Combination therapy methods for treating an inflammatory breast cancer |
| 06/13/2013 | WO2013085877A1 Treatment of amyloidosis by compounds that regulate retromer stabilization |
| 06/13/2013 | WO2013085824A1 Small molecule anti-fibrotic compounds and uses thereof |
| 06/13/2013 | WO2013085802A1 Pyrrolopyrimidines as janus kinase inhibitors |
| 06/13/2013 | WO2013085781A1 Spirothienopyran- piperidine derivatives as orl-1 receptor antagonists for their use in the treatment of alcohol dependence and abuse |
| 06/13/2013 | WO2013085718A1 Multifunctional small molecules |
| 06/13/2013 | WO2013085624A1 Vectors harboring toxic genes, methods and uses therefor |
| 06/13/2013 | WO2013085558A1 Methods and compositions for alteration of skin pigmentation |
| 06/13/2013 | WO2013085483A1 Targeting en2, pax2, and/or defb1 for treatment of prostate conditions |